These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 21535940)

  • 1. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
    Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
    Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells.
    Kang SG; Jeun SS; Lim JY; Kim SM; Yang YS; Oh WI; Huh PW; Park CK
    Childs Nerv Syst; 2008 Mar; 24(3):293-302. PubMed ID: 17968556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas.
    Ströjby S; Eberstål S; Svensson A; Fritzell S; Bexell D; Siesjö P; Darabi A; Bengzon J
    J Neuroimmunol; 2014 Sep; 274(1-2):240-3. PubMed ID: 25086876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
    Zhu X; Lu C; Xiao B; Qiao J; Sun Y
    J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IMMUNOGENICITY OF HUMAN UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELLS AFTER OSTEOGENIC INDUCTION].
    Yang D; Lin H; Liu G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jun; 28(6):752-7. PubMed ID: 26455231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells.
    Kim DS; Kim JH; Lee JK; Choi SJ; Kim JS; Jeun SS; Oh W; Yang YS; Chang JW
    Stem Cells Dev; 2009 Apr; 18(3):511-9. PubMed ID: 18624673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical cord blood stem cells: induction of differentiation into mesenchymal lineages by cell-cell contacts with various mesenchymal cells.
    Park J; Setter V; Wixler V; Schneider H
    Tissue Eng Part A; 2009 Feb; 15(2):397-406. PubMed ID: 18759667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.
    Ryu CH; Park SH; Park SA; Kim SM; Lim JY; Jeong CH; Yoon WS; Oh WI; Sung YC; Jeun SS
    Hum Gene Ther; 2011 Jun; 22(6):733-43. PubMed ID: 21261460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.
    Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ
    Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats.
    Xu G; Jiang XD; Xu Y; Zhang J; Huang FH; Chen ZZ; Zhou DX; Shang JH; Zou YX; Cai YQ; Kou SB; Chen YZ; Xu RX; Zeng YJ
    Cell Biol Int; 2009 Apr; 33(4):466-74. PubMed ID: 18725309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
    Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of umbilical cord-derived mesenchymal stem cells.
    Shawki S; Gaafar T; Erfan H; El Khateeb E; El Sheikhah A; El Hawary R
    Microbiol Immunol; 2015 Jun; 59(6):348-56. PubMed ID: 25869421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-glioma response of autologous T cells stimulated by autologous dendritic cells electrofused with CD133+ or CD133- glioma cells.
    Qin K; Tian G; Li P; Chen Q; Zhang R; Ke YQ; Xiao ZC; Jiang XD
    J Neuroimmunol; 2012 Jan; 242(1-2):9-15. PubMed ID: 22123613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
    Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
    Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
    Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
    Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human umbilical cord blood-derived mesenchymal stem cells inhibit C6 glioma via downregulation of cyclin D1.
    Jiao H; Guan F; Yang B; Li J; Shan H; Song L; Hu X; Du Y
    Neurol India; 2011; 59(2):241-7. PubMed ID: 21483126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
    Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B
    Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.